Rain Therapeutics shares are trading higher after JonesTrading initiated coverage on the stock with a Buy rating and announced a $17 price target.
Rain Therapeutics shares are trading higher after JonesTrading initiated coverage on the stock with a Buy rating and announced a $17 price target.
在Jones Trading以買入評級啟動對該股的報道並宣佈17美元的目標價後,RAIN治療公司的股價上漲。
Rain Therapeutics shares are trading higher after JonesTrading initiated coverage on the stock with a Buy rating and announced a $17 price target.
在Jones Trading以買入評級啟動對該股的報道並宣佈17美元的目標價後,RAIN治療公司的股價上漲。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。